SCHEMBL14219353

SCHEMBL14219353

CCCCC(CC)COC(=O)CNC(=O)CCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.53
ALDH1A1 P00352 3/20 0.52
CYP3A4 P08684 2/20 0.52
CA2 P00918 1/20 0.52
TDP1 Q9NUW8 2/20 0.51
TSHR P16473 1/20 0.51
ATM Q13315 1/20 0.51
LMNA P02545 4/20 0.48
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
HDAC3 O15379 1/20 0.46
MAPK1 P28482 2/20 0.46
KDM4E B2RXH2 2/20 0.45
GAA P10253 1/20 0.44
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
F2 P00734 1/20 0.43
PKM P14618 1/20 0.43
ADRB2 P07550 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19024893 0.87 CYP3A4 (0.64) HPGDALDH1A1CYP3A4CA2TDP1
SCHEMBL19024922 0.83 CYP3A4 (0.67) ALDH1A1CYP3A4CA2TDP1TSHR
SCHEMBL25778290 0.82 CYP3A4 (0.69) ALDH1A1CYP3A4CA2TDP1TSHR
SCHEMBL2719939 0.82 HPGD (0.62) HPGDALDH1A1CYP3A4TDP1TSHR
SCHEMBL14219263 0.81 ALDH1A1 (0.56) ALDH1A1CYP3A4CA2TDP1TSHR
SCHEMBL17616866 0.80 CYP3A4 (0.66) ALDH1A1CYP3A4CA2TDP1TSHR
SCHEMBL17616871 0.79 CYP3A4 (0.64) ALDH1A1CYP3A4CA2TDP1TSHR
SCHEMBL19024941 0.79 ALDH1A1 (0.63) ALDH1A1CYP3A4CA2TDP1TSHR
SCHEMBL3665504 0.79 PPID (0.62) HPGDALDH1A1TDP1LMNAHDAC3
SCHEMBL16345178 0.78 CYP3A4 (0.62) HPGDALDH1A1CYP3A4CA2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1911438-A2 Cosmetic composition containing a derivative of dibenzoylmethane and a arylalkyl amide or ester compound; method of photostabilising the derivative of dibenzoylmethane L'Oréal (FR) 2008-04-16 EP disclosed
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds L'OREAL (FR) 2008-01-24 US disclosed
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds L'OREAL (FR) 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds TYR, DDT, AADAC HPGD 909/4885ALDH1A1 110/4885CYP3A4 485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.